HYPR NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Hyperfine Inc · Healthcare · Medical Devices

Latest close 0.94 USD
-1.9% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -25.5% below the Trend Line and sits at 6.3% of its 52-week range. The latest completed week returned -1.9%, after a -28.0% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 52/100 conviction, while the latest news-sentiment score is 52/100. Near-term considerations: volume confirmation is below normal; earnings are due in 10d.

Setup score 20 out of 100
Latest Close 0.94 USD 31 Jul 2026
1W Return -1.9% latest completed week
4W Return -28.0% short-term follow-through
12W Return -44.6% quarterly tape
Trend Breadth 50.0% 26 of 52 weeks active
Volume Ratio 0.6x vs 13-week average
What is working
  • No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -25.5% below the Trend Line and sits at 6.3% of its 52-week range. The latest completed week returned -1.9%, after a -28.0% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.6x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.4112-week average 0.61

12-week confirmation

Trend active9/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure9/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership6/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.41Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -28.0% over four weeks, -44.6% over 12 weeks, and -9.1% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-1.9%
4W-28.0%
12W-44.6%
26W-16.4%
52W-9.1%
Active trend streak0 weeks
Active weeks in one year26
Trend breadth50.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-1.07Latest activity-pressure read.
Pressure change-534.5%Four-week change in activity pressure.
Leadership-31.18Latest relative-leadership reading.
RS change-254.8%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 82% Model confidence 78%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength7/100Blend of value, momentum, and quality. Underlying universe rank 94; rank 1 is best.
Value23/100Relative valuation strength. Underlying universe rank 78; rank 1 is best.
Quality7/100Profitability and accounting quality. Underlying universe rank 94; rank 1 is best.
Momentum30/100Medium-term price momentum. Underlying universe rank 71; rank 1 is best.
Growth83/100Revenue and earnings growth. Underlying universe rank 18; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
6.2x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-39.8%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
51.2%
Gross profit retained from each unit of revenue.
Operating margin
-226.3%
Operating profit retained from revenue.
Free-cash-flow margin
-174.5%
Free cash flow generated from revenue.
Return on invested capital
-375.2%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
30.7%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-23.5%
Net share repurchases relative to market value.
Shareholder yield
-23.5%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.8x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

HYPR shows volatility options pressure with a 52/100 conviction score, put-call volume ratio of 0.00, expected move of 172.6%, and Sharemaestro trend signal inactive.

Conviction52/100
Expected move172.6%
Put/call volume0.00
Pressure100
Speculation0
Volatility96
Trend agreement0
Open options detail
Insider activity5 / 2

5 acquisitions and 2 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment52/100

Weighted news tone is neutral across 67 relevant articles.

12 positive · 54 neutral · 1 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings10dNext report is scheduled for 12 Aug 2026; event risk rises as the date approaches.
Options expected move172.6%Nearest-chain priced movement where available.
52-week drawdown-57.8%Distance below the 52-week high.
13-week volatility8.9%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher11 of 2614 weeks finished lower.
Best week+45.0%Week of 1 May.
Worst week-16.2%Week of 10 Jul.
Latest week-1.9%Week of 31 Jul.

Shape of recent returns

Strong gains7
Modest gains4
Flat weeks1
Modest losses5
Sharp losses9
Recent vol8.9%13-week weekly-return volatility.
Base vol11.5%52-week weekly-return volatility.
Up/down split24/27Count of positive and negative weeks in the 52-week window.
Average skew9.7% / -7.7%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20260.94 USD-1.9%1.26 USD1.14 USD-1.07-31.182.8MOff
24 Jul 20260.95 USD2.5%1.26 USD1.15 USD-0.87-29.813.1MOff
17 Jul 20260.93 USD-14.6%1.26 USD1.16 USD-0.45-32.955.8MOff
10 Jul 20261.09 USD-16.2%1.27 USD1.17 USD0.04-24.966.4MOn
3 Jul 20261.30 USD-11.6%1.26 USD1.18 USD0.25-8.794.7MOn
26 Jun 20261.47 USD-8.1%1.26 USD1.19 USD0.404.4117.7MOn
19 Jun 20261.60 USD17.6%1.24 USD1.19 USD0.529.295.3MOn
12 Jun 20261.36 USD-1.4%1.22 USD1.20 USD0.50-3.842.2MOn
5 Jun 20261.38 USD-11.5%1.22 USD1.20 USD0.860.332.4MOn
29 May 20261.56 USD4.7%1.21 USD1.20 USD1.228.793.4MOn
22 May 20261.49 USD-3.9%1.19 USD1.20 USD1.467.931.8MOn
15 May 20261.55 USD-8.3%1.19 USD1.20 USD1.4514.793.6MOn
8 May 20261.69 USD-9.6%1.18 USD1.20 USD1.4426.023.1MOn
1 May 20261.87 USD45.0%1.18 USD1.20 USD1.1548.396.9MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.